Search Results 101-110 of 17101 for hla genotype
About this study · To evaluate the pharmacogenomic profile (PGx) by genotyping 22 genes, including the CYP2D6 genotype, in patients with functional GI disorders.
To determine the correlation between the specific subtype of MBL (CD5- MBL, atypical CLL-phenotype MBL and CLL-phenotype MBL) relative to the HCV genotype.
donor, or HLA 1-antigen mismatched unrelated donor, with either bone marrow or peripheral blood stem cells as a graft source, and with any conditioning ...
About this study. This is a Phase II, open-label, two strata, multicenter, prospective study of plerixafor-mobilized HLA-identical sibling allografts in ...
About this study. This study will help the investigator determine whether certain genetic mutations, more than others, are a cause of more severe disease in ...
Mayo Clinic's Cost Estimator Tool can provide an estimate for services to be provided to you, or you may request a formal estimation of services.
Participant must be positive for Human leukocyte antigen (HLA)-A*02:01, HLA-A*02:05, and/or HLA-A*02:06 alleles. Participant's tumor is positive for NY-ESO ...
"For patients who do not have the loss-of-function CYP2C19 genotype, there is no difference in using clopidogrel, as compared to ticagrelor or prasugrel. But ...
The Sponsor will review the results of HLA typing for inclusion alleles, and will adjudicate subject eligibility based on HLA results. ... Positive for any HLA-A* ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.